Clinical Trial

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

Name: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease — clinical trial record (NCT07160790)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated September 8, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD

Trial Details

NCT Number	NCT07160790
Lead Sponsor	Onconic Therapeutics Inc.
Conditions	Non-erosive Gastroesophageal Reflux Disease
Enrollment	321 participants
Start Date	2025-09-02
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-08